✦ LIBER ✦

Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance

✍ Scribed by Horn, Julia; Kleber, Martina; Hieke, Stefanie; Schmitt-Gräff, Annette; Wäsch, Ralph; Engelhardt, Monika

Book ID: 111946811
Publisher: Springer
Year: 2012
Tongue: English
Weight: 175 KB
Volume: 91
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-012-1503-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility and pharmacokinetic study of

Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin’s lymphoma

✍ Michinori Ogura; Kiyoshi Ando; Masafumi Taniwaki; Takashi Watanabe; Toshiki Uchi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Efficacy and Safety of Rituximab Combine

Efficacy and Safety of Rituximab Combined with ESHAP Chemotherapy for the Treatment of Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

✍ Harting, Rekha; Venugopal, Parameswaran; Gregory, Stephanie A.; O'Brien, Teresa; 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 168 KB

Phase II study of bendamustine in combin

Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas

✍ Weidmann, E.; Neumann, A.; Fauth, F.; Atmaca, A.; Al-Batran, S. E.; Pauligk, C.; 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 107 KB

Bendamustine and Rituximab for Indolent

Bendamustine and Rituximab for Indolent B-Cell Non-Hodgkin Lymphoma in Patients With Compensated Hepatitis C Cirrhosis: A Case Series

✍ Parker, Stacey M.; Hyder, Mustafa A.; Fesler, Mark J. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 92 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

Bendamustine is effective therapy in pat

Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma : Results from a Multicenter Study

✍ Brad S. Kahl; Nancy L. Bartlett; John P. Leonard; Ling Chen; Kristen Ganjoo; Mic 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB